Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma
about
Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesisHigh expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinomaPotential biomarkers associated with diabetic glomerulopathy through proteomics.Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate.Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.Prognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue.Aldo-keto reductase family 1 member B10 is associated with hepatitis B virus-related hepatocellular carcinoma risk.Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection.Genomic variants link to hepatitis C racial disparities.Metallothionein 1M suppresses tumorigenesis in hepatocellular carcinoma.Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes.Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy ReactionIntegrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma
P2860
Q33580721-F716C975-85F0-4981-AF84-5FC2BBC1F55DQ34432183-B95F60F9-DA0F-4BFB-902A-DA7F7953F027Q35771804-788AA8F3-70DC-4FC4-9C2F-F1FB6CE09E4EQ36629475-FA74B31D-A1F3-4047-B373-6FC426E7EAE2Q36656870-96109DF7-A529-4715-9BA5-9E7F4961C209Q37232717-A2FD1AA3-6F28-4205-9B00-F623ACEA19A4Q37582227-964D289D-D8CE-492B-B52A-251D5288FF85Q40712186-31E9338A-767B-4F3E-9703-FD3DBCECAAA8Q40835917-9FE16D6B-95A6-4B14-AAF0-5E0A7B84B4DDQ41610203-43C1EDF3-8BE8-45A4-865E-25193E1B47F6Q41708713-DD33F710-950E-4111-A902-3B3EC9E334A4Q42212638-FD57AF4E-35B0-43EC-9E62-DDB83515A972Q55442577-C5E131F0-E475-4D3C-AEF0-86D3D11F3231Q57492406-E10C9562-32E5-486F-8E66-545CFFB40C9EQ58733819-58F61E31-8028-4C30-A400-EF1F5092C5AC
P2860
Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@ast
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@en
type
label
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@ast
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@en
prefLabel
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@ast
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@en
P2093
P2860
P1433
P1476
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@en
P2093
Hironori Tsuzura
Katsuharu Hirano
Katsuyori Iijima
Shunsuke Sato
Takafumi Ichida
Takuya Genda
Tetsu Kikuchi
Yoshio Kanemitsu
Yutaka Narita
P2860
P304
P356
10.1111/J.1478-3231.2012.02827.X
P577
2012-06-11T00:00:00Z